Introduction

Welcome to Lipidor ABs IR pages

Lipidor is a pharmaceutical development company with a pipeline of drug development projects in preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections and atopic dermatitis. With Lipidor’s patented formulation technology AKVANO, well-proven drugs, whose patent time has expired or will expire, can be reformulated and improved in terms of efficacy, side effects, and ease of use (so-called supergenerics). This means that Lipidor has the opportunity of taking significant market shares from existing products, increasing the market potential for the relevant drug substance and also obtaining market exclusivity during AKVANO’s patent period.

Lipidor was founded in 2009 by leading lipid researchers and based on a vision to develop a user-friendly and effective drug delivery method for topical application of drugs. The first patent applications for the Company’s technology were submitted in 2009.